PMID: 9547346May 23, 1998Paper

A survey of the humoral immune response of cancer patients to a panel of human tumor antigens

The Journal of Experimental Medicine
E StockertL J Old

Abstract

Evidence is growing for both humoral and cellular immune recognition of human tumor antigens. Antibodies with specificity for antigens initially recognized by cytotoxic T lymphocytes (CTLs), e.g., MAGE and tyrosinase, have been detected in melanoma patient sera, and CTLs with specificity for NY-ESO-1, a cancer-testis (CT) antigen initially identified by autologous antibody, have recently been identified. To establish a screening system for the humoral response to autoimmunogenic tumor antigens, an enzyme-linked immunosorbent assay (ELISA) was developed using recombinant NY-ESO-1, MAGE-1, MAGE-3, SSX2, Melan-A, and tyrosinase proteins. A survey of sera from 234 cancer patients showed antibodies to NY-ESO-1 in 19 patients, to MAGE-1 in 3, to MAGE-3 in 2, and to SSX2 in 1 patient. No reactivity to these antigens was found in sera from 70 normal individuals. The frequency of NY-ESO-1 antibody was 9.4% in melanoma patients and 12.5% in ovarian cancer patients. Comparison of tumor NY-ESO-1 phenotype and NY-ESO-1 antibody response in 62 stage IV melanoma patients showed that all patients with NY-ESO-1(+) antibody had NY-ESO-1(+) tumors, and no patients with NY-ESO-1(-) tumors had NY-ESO-1 antibody. As the proportion of melanomas expre...Continue Reading

References

Sep 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·H TowbinJ Gordon
Nov 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·B S KwonR Halaban
Jun 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·A KnuthL J Old
Jun 1, 1995·Immunological Reviews·M A CheeverW Chen
Aug 29, 1995·Proceedings of the National Academy of Sciences of the United States of America·Y T ChenL J Old
Mar 28, 1995·Proceedings of the National Academy of Sciences of the United States of America·K KitamuraL J Old
Feb 1, 1994·Proceedings of the National Academy of Sciences of the United States of America·Y T ChenL J Old
Dec 5, 1995·Proceedings of the National Academy of Sciences of the United States of America·U SahinM Pfreundschuh
Oct 1, 1995·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E T LennetteG Klein
Mar 1, 1996·The Journal of Experimental Medicine·T Boon, P van der Bruggen
Jun 11, 1996·Proceedings of the National Academy of Sciences of the United States of America·Y T ChenL J Old
Dec 11, 1995·International Journal of Cancer. Journal International Du Cancer·M MarchandY Humblet
Oct 1, 1996·Current Opinion in Immunology·R W Tindle
Mar 4, 1997·Proceedings of the National Academy of Sciences of the United States of America·Y T ChenL J Old
Aug 1, 1997·Molecular Medicine Today·O TüreciM Pfreundschuh

❮ Previous
Next ❯

Citations

Nov 24, 1999·International Journal of Cancer. Journal International Du Cancer·R PasquinelliJ Guardiola
Mar 4, 2000·International Journal of Cancer. Journal International Du Cancer·A O GüreY T Chen
Mar 30, 2000·The Journal of Gene Medicine·G Dranoff
Dec 7, 2000·Genes, Chromosomes & Cancer·N R dos SantosA G van Kessel
Mar 20, 2002·Cancer·Mirjana Urosevic, Reinhard Dummer
Sep 5, 2002·International Journal of Cancer. Journal International Du Cancer·Murray B ResnickEvgeny Yakirevich
May 15, 2001·International Journal of Cancer. Journal International Du Cancer·A A JungbluthL J Old
Aug 24, 2001·International Journal of Cancer. Journal International Du Cancer·R C RooversH R Hoogenboom
Oct 23, 2001·International Journal of Cancer. Journal International Du Cancer·A A JungbluthL J Old
Nov 25, 2000·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Y ObataS Miura
Jul 22, 2005·Cancer Immunology, Immunotherapy : CII·Emma E FurthDorothee Herlyn
May 24, 2006·Cancer Immunology, Immunotherapy : CII·Alfred ZippeliusDirk Jaeger
Dec 23, 2006·Cancer Immunology, Immunotherapy : CII·Emmanuelle GodefroyMaha Ayyoub
Mar 4, 2008·Cancer Immunology, Immunotherapy : CII·Kazuhide TsujiKeiji Iwatsuki
Jun 2, 2010·Cancer Immunology, Immunotherapy : CII·A HellerN A Giese
May 1, 2004·Cancer Chemotherapy and Pharmacology·Argun AkcakanatKatsuyoshi Hatakeyama
Jun 21, 2005·Springer Seminars in Immunopathology·Adrian F Ochsenbein
Sep 28, 2007·Journal of Cancer Research and Clinical Oncology·Yi ShaoHai-Tao Zhao
Aug 20, 2010·Glycoconjugate Journal·Catharina SteentoftHenrik Clausen
May 25, 2012·Medical & Biological Engineering & Computing·F J LopezA Blanco
May 15, 2004·Cancer Letters·Axel GerhardtStefan Eichmüller
Dec 9, 2003·Journal of Immunological Methods·Patricia KrauseUgur Sahin
Sep 11, 2001·The American Journal of Pathology·M LuE M Tan
Feb 24, 2001·The Annals of Thoracic Surgery·T S WeiserD S Schrump
Sep 27, 2003·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Kouhei TajimaTetsuya Mitsudomi
Sep 6, 2002·Cancer Letters·Ann De JongDick Robbins
Jul 6, 2002·Critical Reviews in Oncology/hematology·Rong-Fu WangHan Ying
Aug 9, 2005·Journal of Proteome Research·Karen S Anderson, Joshua LaBaer
Oct 28, 2010·Journal of Proteome Research·Karen S AndersonJoshua Labaer
May 3, 2008·Journal of Proteome Research·Tasneem H PatwaDavid M Lubman
Sep 1, 2012·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Jessica A HemmingerO Hans Iwenofu
Jul 24, 2004·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Dhananjay A ChitaleRobert A Soslow
Mar 14, 2003·Nature·Sam Hanash
Jan 4, 2003·Nature Biotechnology·Sam Hanash
Aug 29, 2002·Clinical and Experimental Immunology·E A WatermanA P Weetman
May 1, 2001·Immunology·D M BrownE M Lord

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
Y T ChenL J Old
Proceedings of the National Academy of Sciences of the United States of America
Ugur SahinM Pfreundschuh
The Journal of Experimental Medicine
L J Old, Y T Chen
Proceedings of the National Academy of Sciences of the United States of America
E JägerA Knuth
© 2022 Meta ULC. All rights reserved